Omega-3s & nutritional oils

Frutarom jumps into the omega-3 sea

Frutarom jumps into the omega-3 sea

The health division of Swiss ingredients player Frutarom has launched omega-3s for the first time with the company noting their potential in heart, brain and eye health along with inflammation and general well-being.

NanoSphere Health CSO: ‘We’re revolutionizing the way of delivering nutrients’

Special edition: Innovations in Delivery Systems

NanoSphere Health CSO: ‘We’re revolutionizing the way of delivering nutrients’

By Stephen DANIELLS

Disruptive technologies to produce natural nano-sized nutraceuticals could ‘revolutionize’ how dietary supplements deliver their benefits, with smaller most definitely better for enhancing bioavailability and bio-efficacy, says the CSO of NanoSphere Health...

Omega-3 sustainability drive steps up a gear

Omega-3 sustainability drive steps up a gear

By Lynda Searby

Functional food and supplement producer Bio-Life SPRL claims to have become the first company in Belgium and France to offer fish oil derived omega-3 supplements with sustainability certification, as the drive to have origins audited by Friend of the...

Metabolites of EPA, DHA ripe area for innovation, expert says

Metabolites of EPA, DHA ripe area for innovation, expert says

By Hank Schultz

Innovation in omega-3s has come in many forms.  New delivery modes, new raw material sources, and new chemical forms.  But through it all, the story has always been about  EPA and DHA as whole molecules. That might be about to change.

FMC to split into two publicly traded companies

FMC to split into two publicly traded companies

By Hank Schultz

FMC Corporation, owner of omega 3 fish oils leader EPAX, will split into two publically traded companies, the corporation announced recently.  The plan is to split the agricultural and nutrition segments off from the company’s industrial minerals divisions.

Is the omega-3 sector in decline?

Is the omega-3 sector in decline?

By Stephen DANIELLS

Growth in fish oil sales have been described by the CEO of Vitamin Shoppe as ‘softening’, while data from GOED indicates that 12 million users have left the category in the US, so is the omega-3 sector in decline?

Not enough beta-palmitate, youngster?...

Mud in your eye: EFSA rejects vision and stool claims

By Shane STARLING

Replacing vegetable oils with an esterified vegetable oil in infant formulas will not soften infant stools, and a choline form will not boost vision, the European Food Safety Authority (EFSA) has found.

Caviar emptor: Herring omega-3 gains UK debut

Caviar emptor: Herring omega-3 gains UK debut

By Shane Starling

Major natural foods retailer Whole Foods Market is launching a herring caviar-based, phospholipid-imbued omega-3 supplement at its UK stores from March 1.

Omega-3 backed for Alzheimer’s disease potential

Omega-3 backed for Alzheimer’s disease potential

By Nathan Gray

Supplementation with omega-3 fatty acids could help to prevent and even reverse the progression of Alzheimer’s disease by stimulating newly identified ‘resolution pathways’, according to research outlining an ‘entirely new’ approach to the condition.

Nutritional Lipids and Oils online event: TODAY

Register now for our exclusive free to attend event

Nutritional Lipids and Oils online event: TODAY

By Nathan Gray

Our exclusive online event, offering the latest market information and scientific insights in for the nutritional lipids and oils market takes place today. But it's not too late to register.

DSM applies for DHA omega-3 brain health claim

EU health claim submissions

DSM applies for DHA omega-3 brain health claim

By Shane Starling

DSM Nutritional Products (DNP) has applied for an article 14 claim linking omega-3 and brain function under the European Union nutrition and health claims regulation (NHCR).

GM omega-3? UK could see GM 'fish oil' trial this year

GM omega-3? UK could see GM 'fish oil' trial this year

By Nathan Gray

Rothamsted Research has submitted an application to the UK government requesting permission to carry out a field trial for genetically modified plants that are rich in long-chain omega-3 fatty acids.

DSM: A “confluence of completely unrelated events” has affected its 2013 results

DSM profits rise in 2013 despite sluggish nutrition performance

By Shane STARLING

Multiple issues in the omega-3 sector, a ‘saturated’ US food supplements market, a widespread consumer move to private label plus a strengthening euro have all impacted Dutch-Swiss ingredient giant DSM’s nutrition division in 2013, but it still delivered...

Follow us

Product Innovations